FDA Inspection
AlloSourceAlloSource – FDA Inspection, Aug 4, 2025
Record Details
This FDA Inspection record concerns AlloSource, with an inspection on August 4, 2025, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ca5f26f3-640f-4459-80ae-a2e03dafef5a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1278944
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of AlloSource
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 3, 2008 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for AlloSource
- FDA Inspection 1083311 - 2019-02-26
- FDA Inspection 544221 - 2008-10-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.